Mifepristone Makers, FDA Say Louisiana Lacks Standing In Dispensing Dispute
NEW ORLEANS — The manufacturers of mifepristone, one of two drugs used to induce early termination of pregnancy, and the U.S. Food and Drug Administration filed separate briefs urging the Fifth...To view the full article, register now.
Already a subscriber? Click here to view full article